Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 120

    1.

    Methylene blue and cirrhosis: pathophysiologic insights, therapeutic dilemmas.

    Fallon MB.

    Ann Intern Med. 2000 Nov 7;133(9):738-40. No abstract available. PMID: 11074907 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Methylene blue improves the hepatopulmonary syndrome.

    Schenk P, Madl C, Rezaie-Majd S, Lehr S, Müller C.

    Ann Intern Med. 2000 Nov 7;133(9):701-6.PMID: 11074903 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome.

    Jounieaux V, Leleu O, Mayeux I.

    Intensive Care Med. 2001 Jun;27(6):1103-4. No abstract available. PMID: 11497151 [PubMed - indexed for MEDLINE]Related articles

    4.

    Methylene blue improves the hepatopulmonary syndrome.

    Groneberg DA, Fischer A.

    Ann Intern Med. 2001 Sep 4;135(5):380-1. No abstract available. PMID: 11529704 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome.

    Almeida JA, Riordan SM, Liu J, Galhenage S, Kim R, Bihari D, Wegner EA, Cranney GB, Thomas PS.

    Eur J Gastroenterol Hepatol. 2007 Apr;19(4):341-6.PMID: 17353701 [PubMed - indexed for MEDLINE]Related articles

    6.

    N(G)-nitro-L-arginine methyl ester, but not methylene blue, attenuates anaphylactic hypotension in anesthetized mice.

    Takano H, Liu W, Zhao Z, Cui S, Zhang W, Shibamoto T.

    J Pharmacol Sci. 2007 Jul;104(3):212-7. Epub 2007 Jun 29.PMID: 17598952 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass.

    Evora PR, Levin RL.

    J Thorac Cardiovasc Surg. 2004 Mar;127(3):895-6; author reply 896. No abstract available. PMID: 15001923 [PubMed - indexed for MEDLINE]Related articles

    8.

    The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation.

    Koelzow H, Gedney JA, Baumann J, Snook NJ, Bellamy MC.

    Anesth Analg. 2002 Apr;94(4):824-9, table of contents.PMID: 11916779 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The soluble guanylate cyclase inhibitor methylene blue evokes preterm delivery and fetal growth restriction in a mouse model.

    Tiboni GM, Giampietro F, Lamonaca D.

    In Vivo. 2001 Jul-Aug;15(4):333-7.PMID: 11695226 [PubMed - indexed for MEDLINE]Related articles

    10.

    Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass?

    Leyh RG, Kofidis T, Strüber M, Fischer S, Knobloch K, Wachsmann B, Hagl C, Simon AR, Haverich A.

    J Thorac Cardiovasc Surg. 2003 Jun;125(6):1426-31.PMID: 12830064 [PubMed - indexed for MEDLINE]Related articles

    11.

    Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis.

    Grayling M, Deakin CD.

    J Thorac Cardiovasc Surg. 2003 Feb;125(2):426-7. No abstract available. PMID: 12579121 [PubMed - indexed for MEDLINE]Related articles

    12.

    Methylene blue for refractory hypotension: a case report.

    Weissgerber AJ.

    AANA J. 2008 Aug;76(4):271-4. Review.PMID: 18777811 [PubMed - indexed for MEDLINE]Related articles

    13.

    Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.

    Fernandes D, da Silva-Santos JE, Duma D, Villela CG, Barja-Fidalgo C, Assreuy J.

    Mol Pharmacol. 2006 Mar;69(3):983-90. Epub 2005 Dec 2.PMID: 16326931 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Methylene blue in the hepatopulmonary syndrome.

    Rolla G, Bucca C, Brussino L.

    N Engl J Med. 1994 Oct 20;331(16):1098. No abstract available. PMID: 8090178 [PubMed - indexed for MEDLINE]Related articles

    15.

    The guanylyl cyclase inhibition by MB as vasoplegic circulatory shock therapeutical target.

    Evora PR, Viaro F.

    Curr Drug Targets. 2006 Sep;7(9):1195-204. Review.PMID: 17017895 [PubMed - indexed for MEDLINE]Related articles

    16.

    Combination of intravenously infused methylene blue and inhaled nitric oxide ameliorates endotoxin-induced lung injury in awake sheep.

    Kirov MY, Evgenov OV, Bjertnaes LJ.

    Crit Care Med. 2003 Jan;31(1):179-86.PMID: 12545013 [PubMed - indexed for MEDLINE]Related articles

    17.

    Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue.

    Evora PR, Simon MR.

    Ann Allergy Asthma Immunol. 2007 Oct;99(4):306-13. Review.PMID: 17941276 [PubMed - indexed for MEDLINE]Related articles

    18.

    Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome.

    Zhang J, Ling Y, Luo B, Tang L, Ryter SW, Stockard CR, Grizzle WE, Fallon MB.

    Gastroenterology. 2003 Nov;125(5):1441-51.PMID: 14598260 [PubMed - indexed for MEDLINE]Related articles

    19.

    The hepatopulmonary syndrome: NO way out?

    Dinh-Xuan AT, Naeije R.

    Eur Respir J. 2004 May;23(5):661-2. Review. No abstract available. PMID: 15176675 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effects of an NO-synthase inhibitor L-NMMA in the hepatopulmonary syndrome.

    Maniscalco M, Sofia M, Higenbottam T.

    Respiration. 2001;68(2):226. No abstract available. PMID: 11287843 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data